Fidelity Disruptive Medicine ETF
FMED
FMED
7 hedge funds and large institutions have $27.9M invested in Fidelity Disruptive Medicine ETF in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$16.3M |
| 2 |
2
Jane Street
New York
|
$730K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $16.3M | 737,997 | -19,697 | -3% |
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $10.3M | 465,986 | +465,986 | New |
|
|
3
Jane Street
New York
| $730K | 32,999 | -3,439 | -9% |
|
|
VF
4
Virtu Financial
New York
| $493K | 22,261 | +22,261 | New |
|
5
UBS Group
Zurich,
Switzerland
| $2.61K | 118 | +118 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $2.48K | 112 | +112 | New |
|
|
HI
7
Harbour Investments
Madison,
Wisconsin
| $907 | 41 | – | – |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|